Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
690
Views
7
CrossRef citations to date
0
Altmetric
REVIEW

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction

Ali A Rizvi1 Department of Medicine, University of Central Florida College of Medicine, Orlando, Florida, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3714-0790
ORCID Icon &
Manfredi Rizzo2 Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, ItalyORCID Iconhttps://orcid.org/0000-0002-9549-8504
ORCID Icon
Pages 1023-1030 | Published online: 05 Apr 2022

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dimitrios Patoulias, Massimiliano Caprio, Anca Pantea Stoian & Manfredi Rizzo. (2023) Tirzepatide and glucagon-like peptide-1 receptor agonists: safety always comes first!. Expert Opinion on Drug Safety 22:9, pages 763-765.
Read now

Articles from other publishers (6)

Hikmat Permana, Theo Audi Yanto & Timotius Ivan Hariyanto. (2022) Efficacy and safety of tirzepatide as novel treatment for type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:11, pages 102640.
Crossref
Tomislav Bulum. (2022) Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists. Biomedicines 10:10, pages 2586.
Crossref
Elena Jiménez-Martí, Gema Hurtado-Genovés, María Aguilar-Ballester, Sergio Martínez-Hervás & Herminia González-Navarro. (2022) Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists. Nutrients 14:18, pages 3775.
Crossref
Hiroaki Yagyu & Hitoshi Shimano. (2022) Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease. Journal of Diabetes Investigation 13:9, pages 1472-1488.
Crossref
Jelena Vekic, José Silva-Nunes & Manfredi Rizzo. (2022) Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment. Metabolites 12:8, pages 712.
Crossref
Emir M. Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P. Mikhailidis, Manfredi Rizzo & Christos S. Mantzoros. (2022) Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence. Journal of Cardiovascular Pharmacology and Therapeutics 27, pages 107424842211463.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.